✦ LIBER ✦

Diabetes and Cardiovascular Disease || The Use of Animal Models to Study Diabetes and Atherosclerosis and Potential Anti-Atherosclerotic Therapies

✍ Scribed by Johnstone, Michael T.; Veves, Aristidis

Book ID: 120222081
Publisher: Humana Press
Year: 2005
Weight: 344 KB
Category: Article
ISBN: 1592599087
DOI: 10.1385/1-59259-908-7:259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diabetes and Cardiovascular Disease: The

Diabetes and Cardiovascular Disease: The Potential Benefit of Incretin-Based Therapies

✍ Daniel Addison; David Aguilar 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 163 KB

A pragmatic answer to the use of animal

A pragmatic answer to the use of animal models for Type 1 diabetes

✍ Buschard, Karsten 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 1 views

The study of the immunopathogenesis of IDDM in patients is hampered by several restrictions: 1. The onset of IDDM is relatively late in the natural history of the immune process since almost 80-90% of islets have to be destroyed before insulin deficiency is diagnosed. 2. The site of the immune pro

Small animal models of cardiovascular di

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis

✍ James C. Russell; Spencer D. Proctor 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Animal Models in Diabetes Research || Di

Animal Models in Diabetes Research || Diabetes in Mice with Monogenic Obesity: The db/db Mouse and Its Use in the Study of Cardiac Consequences

✍ Joost, Hans-Georg; Al-Hasani, Hadi; Schürmann, Annette 📂 Article 📅 2012 🏛 Humana Press ⚖ 300 KB

The impact of site and extent of clinica

The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study

✍ P. M. Gorter; F. L. J. Visseren; A. Algra; Y. Van Der Graaf; on behalf of the SM 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

CALCULATING CARDIOMETABOLIC RISK: A DISE

CALCULATING CARDIOMETABOLIC RISK: A DISEASE SIMULATION MODEL TO ESTIMATE THE LIFETIME RISK OF COMPLICATIONS OF CARDIOVASCULAR DISEASE AND DIABETES

✍ Grover, S.; Joseph, L.; Kaouache, M.; Remple, P.; Lowensteyn, I. 📂 Article 📅 2014 🏛 Pulsus Group Inc 🌐 English ⚖ 158 KB